Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease—Clinical Practice Position Statement of the Polish Society of Nephrology

Chronic kidney disease (CKD) is a modern epidemic worldwide. Introducing renin–angiotensin system (RAS) inhibitors (i.e., ACEi or ARB) not only as blood-pressure-lowering agents, but also as nephroprotective drugs with antiproteinuric potential was a milestone in the therapy of CKD. For decades, thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Stompór, Tomasz, Adamczak, Marcin, Kurnatowska, Ilona, Naumnik, Beata, Nowicki, Michał, Tylicki, Leszek, Winiarska, Agata, Krajewska, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455736/
https://www.ncbi.nlm.nih.gov/pubmed/37629226
http://dx.doi.org/10.3390/jcm12165184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455736/
https://www.ncbi.nlm.nih.gov/pubmed/37629226
http://dx.doi.org/10.3390/jcm12165184

Ejemplares similares